@Article{Pawlicki2005,
journal="Contemporary Oncology/Współczesna Onkologia",
issn="1428-2526",
volume="9",
number="6",
year="2005",
title="The impact of erythropoietin treatment of anemia on the effectiveness of chemotherapy: analysis of selected parameters and clinical data",
abstract="Anemia is a frequent complication of cancer. It may be exclusively a consequence of the presence of malignant disease itself (cancer-related anemia; CRA) or a result of cancer treatment methods, radiotherapy and/or cytotoxic chemotherapy (radio- and chemotherapy-induced anemia). The aim of the presented study was to evaluate effectiveness of anemia treatment with erythropoietin. Pivotal groups of 68 patients were treated with erythropoietin due to cancer-related anemia occurring before or in the course of chemotherapy. The percentage of patients (52.4%) with an observed increase in the hemoglobin level (at least by 2 g/dl) was lower than data published in other studies. The treatment was well tolerated. Only in one case (1.47%) it was necessary to discontinue treatment because of deep vein thrombosis. The effectiveness of erythropoietin treatment seems to depend on the patients\' condition, pretreatment hemoglobin level (<8.5 g/dl) and duration of chemotherapy.",
author="Pawlicki, Marek
and Kulpa, Jan
and Żuchowska, Beata
and Rychlik, Urszula
and Stasik, Zofia",
pages="237--240",
url="https://www.termedia.pl/The-impact-of-erythropoietin-treatment-of-anemia-on-the-effectiveness-of-chemotherapy-analysis-of-selected-parameters-and-clinical-data,3,3648,1,1.html"
}